KABRA DRUGS LTD. Share Price

KABRA DRUGS LTD. Share Price

BSE: 524322
|
Pharmaceuticals
|
S Cap
₹ 24.28
+₹0.31 (1.29%)
1D
Last updated 11 Aug, 2026, 13:53 IST

KABRA DRUGS LTD. Share Price Today

As of 11 Aug 2026, KABRA DRUGS LTD. share price is ₹24.28. The stock opened at ₹24.05, compared to its previous close of ₹23.97. During today's trading session, KABRA DRUGS LTD. share price moved in the range of ₹23.55 to ₹24.44, with an average price of ₹24.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹15.50 and a high of ₹35.52.

₹23.55
1.29% up today
₹24.44
1D LOW
1D HIGH

KABRA DRUGS LTD. Returns Calculator

Circuit
L
H
₹19.18
₹28.76
52-week
L
H
₹15.50
₹35.52

About KABRA DRUGS LTD.

KABRA DRUGS LTD. Share Price
ISIN
INE323K01017
Sector Market Cap
₹ 56.83 Cr

KABRA DRUGS LTD. Financial Highlights

  • Revenue: KABRA DRUGS LTD. reported revenue of ₹93.23 crore in FY26 vs ₹0.64 crore in FY25. It showed an increase of 14,467.19% on a yearly basis.
  • Operating Profit: KABRA DRUGS LTD. reported an operating profit of ₹5.72 crore in FY26 vs ₹1.09 crore in FY25. It showed an increase of 624.77% on a year-on-year basis.
  • Net Profit: KABRA DRUGS LTD. reported a net profit of ₹4.96 crore in FY26 vs ₹1.09 crore in FY25. It showed an increase of 555.05% on a yearly basis.

KABRA DRUGS LTD. Quarterly Result Highlights

  • KABRA DRUGS LTD. reported revenue of ₹35.52 crore in Mar 2026, compared with ₹30.60 crore in Dec 2025, representing an increase of 16.08% on a quarter-on-quarter (QoQ) basis.
  • KABRA DRUGS LTD. reported an operating profit of ₹1.42 crore in Mar 2026, compared with ₹2.60 crore in Dec 2025, representing a decrease of 45.38% on a quarter-on-quarter (QoQ) basis.
  • KABRA DRUGS LTD. reported a profit of ₹1.06 crore in Mar 2026, compared with ₹2.57 crore in Dec 2025, reflecting a decrease of 58.75% on a QoQ basis.
  • The earnings per share (EPS) of KABRA DRUGS LTD. stood at ₹0.99 during Mar 2026.
Know more
Promoters
0.00%
FII
0.00%
Other DII
0.00%
Retail and other
100.00%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
56.83
P/E
11.47
P/B
1.92
ROE
16.75%
D/E
0.02
ROCE
19.05%
Div. Yield
0.00%
EPS(TTM)
2.09
Turnover
3.12
EV/EBITDA
8.23
Net Margin
0.00%
Op. Margin
0.00%
ROA
5.76%
Quick Ratio
0.00
Curr. Ratio
1.50
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Kabra Drugs outperforming all market indices
Step 2 of 5
Valuation
Expensive
Kabra Drugs PE is significantly higher than its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,68,530.0038.675.6113.74%0.6117.33%93.240.82%0.4810.90
Divis Laboratories2,19,675.0075.1013.1115.32%0.0019.56%629.490.36%0.5598.19
Torrent Pharmaceuticals1,86,970.0086.7222.2325.49%1.6913.85%222.760.69%0.4958.70
Cipla1,17,945.0035.153.4311.27%0.0014.95%423.360.89%0.4543.52
Zydus Lifesciences1,11,790.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,04,020.0018.744.6323.76%0.0424.88%659.050.79%0.57129.18
Mankind Pharma1,00,688.0048.706.1811.74%0.3413.13%397.020.04%0.4449.37
Laurus Labs1,00,822.0092.4719.0216.77%0.4016.14%97.200.11%0.6713.72
Dr. Reddy's Laboratories96,601.2030.342.5411.07%0.1812.54%377.960.69%0.4138.68
Aurobindo Pharma95,600.0025.762.529.25%0.1911.76%391.140.24%0.3841.58

KABRA DRUGS LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹0.00₹0.00₹0.00₹0.00
Other Income₹0.64₹0.00₹0.01₹0.00
Total Revenue₹0.64₹0.00₹0.01₹0.00
Total Expenses₹1.73₹0.74₹0.34₹0.19
Profit Before Tax-₹1.09-₹0.74-₹0.34-₹0.19
Tax₹0.00₹0.00₹0.00₹0.00
Profit After Tax-₹1.09-₹0.74-₹0.34-₹0.19
EPS - Basic-₹0.99-₹1.68-₹0.77-₹0.42
EPS - Diluted-₹0.99-₹1.68-₹0.77-₹0.42

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹1.09-₹0.74-₹0.34-₹0.19
Income before WC changes-₹1.08-₹0.74-₹0.34-₹0.18
Change in Assets-₹1.99-₹1.20₹0.03₹0.65
Change in Liabilities-₹1.64₹1.73-₹0.04-₹0.61
Change in WC-₹3.63₹0.53-₹0.02₹0.04
Cash flow from Operations-₹4.71-₹0.21-₹0.35-₹0.13
Cash flow from Investing-₹0.05₹0.00₹0.00₹0.00
Cash flow from Financing₹23.39₹2.88₹0.36₹0.13
Total Cash Flow₹18.63₹2.67₹0.00-₹0.01
Cash (Start of the year)₹2.67₹0.00₹0.00₹0.01
Cash (End of the year)₹21.30₹2.67₹0.00₹0.00

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹0.07₹0.02₹0.02₹0.02
Current Assets₹25.16₹4.55₹0.68₹0.71
Total Assets₹25.23₹4.57₹0.70₹0.73
Current Liabilities₹0.57₹3.49₹1.43₹1.12
Net Current Asset₹24.59₹1.06-₹0.75-₹0.42
Non-Current Liabilities₹0.00₹0.00₹0.00₹0.00
Equity Capital₹24.65₹1.08-₹0.73-₹0.39
Total Equity & Liabilities₹25.23₹4.57₹0.70₹0.73
* All values are in INR Crore
Qty
Bid
100
24.1
10
24
500
23.82
500
23.81
2820
23.77
Ask
Qty
24.28
43
24.3
50
24.31
44
24.43
78
24.69
71
Bid Total: 3930
Ask Total: 286
Buy orders: 93%
Sell orders: 7%
Bearish
0
Neutral
6
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
53.25
Neutral
ATR (14)
1.65
Neutral
STOCH(9,6)
34.52
Neutral
STOCH RSI (14)
48.17
Neutral
ADX(9)
16.69
Bullish
UO(9)
38.89
Neutral
ROC(12)
5.87
Bullish
WillR(14)
-34.66
Neutral
Period
Simple value
Exponential vaue
5D
23.97
24.02
10D
24.26
23.94
20D
23.26
23.64
50D
23.22
23.74
100D
24.7
24.84
Volume trend — traded volume by day
11 Aug0L
10 Aug0L
7 Aug0L
6 Aug0L
5 Aug0L
4 Aug0L
Average0L
Compare against other stocks
KABRA DRUGS LTD. Share Price
KABRA DRUGS LTD.
Pharmaceuticals
Add Stock
Add Another

KABRA DRUGS LTD. Share Price FAQs